Cipla share price closes near day high at ₹1,419.90; gains 1.15%
Veena Lathe
- 0 min read
Last Updated: 11th November 2026 - 05:15 pm
Key Takeaways
- Cipla ended at ₹1,419.90, up 1.15%, just ₹0.10 below its session high of ₹1,420.
- The stock closed above the 50-day, 100-day and 200-day DMAs, with the 200-day average at ₹1,394.60.
- One-month return was 9.14%, while three-month and one-year performance remained negative at 3.26% and 6.06%.
Cipla share price closed November 11 at ₹1,419.90, gaining 1.15%. The stock opened at ₹1,416 against a previous close of ₹1,404. Its session low was ₹1,406 and the high was ₹1,420, producing a narrow ₹14 trading range. The close finished only ₹0.10 below the high and ₹13.90 above the low, making its final position within the day's range particularly clear.
Volume stood at 1,796,378 shares. Cipla also closed above all three moving-average references. The 50-day DMA was ₹1,374.70, leaving the final price ₹45.20 higher. The 100-day DMA stood at ₹1,382.30 and the 200-day DMA at ₹1,394.60. The close was therefore ₹25.30 above the 200-day level.
The stock's 52-week low was ₹1,166 and the high was ₹1,540. November 11 ended ₹253.90 above the annual low and ₹120.10 below the annual high. Its ₹374 annual range was considerably wider than the ₹14 movement recorded during this individual session.
Return readings varied across periods. Cipla had gained 9.14% over one month, while three-month performance stood at -3.26%. The six-month return was 5.41%, and the one-year reading was -6.06%. The spread between the one-month and one-year figures was 15.20 percentage points. The November 11 close near the session high and above all tracked moving averages therefore contrasted with negative returns over three months and one year.
Frequently Asked Questions
What was the Cipla share price on November 11?
What was Cipla's intraday range?
Was Cipla above its 200-day DMA?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.